	Ventes		Date
AbbVie	USD 16.62B	840M	2025-12
Acadia Pharmaceuticals	USD 278.6M	14M	2025-09
ALKERMES	USD 394.2M	3.5M	2025-09
Amgen	USD 9.9B	340M	2025-12
Biogen	USD 2.28B	250M	2025-12
BioMarin Pharmaceutical	USD 776M	49M	2025-09
Bristol-Myers Squibb	USD 12.5B	300M	2025-12
Coherus Biosciences	USD 7.6M	46.54M	2025-03
Eli Lilly	USD 19.3B	1.7B	2025-12
Gilead Sciences	USD 7.93B	130M	2025-12
Heron Therapeutics	USD 32.81M	3.21M	2024-09
Ionis Pharmaceuticals	USD 157M	295M	2025-09
J&J	USD 24.6B	610M	2025-12
Merck	USD 16.4B	880M	2025-12
Minerva Neurosciences	USD 0	0	2024-09
Nektar Therapeutics	USD 24.12M	635K	2024-09
Neurocrine Biosciences	USD 805.5M	10.6M	2025-12
Otsuka Holdings	JPY 650.15B	12.17B	2025-12
Pfizer	USD 17.58B	880M	2025-12
Regeneron Pharmaceuticals	USD 3.88B	130M	2025-12
Vertex Pharmaceuticals	USD 3.19B	110M	2025-12

ALKERMES Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.